Amir Bahreini
-
- Cancer-related Molecular Pathways 3
- Cancer Cells and Metastasis 2
- HER2/EGFR in Cancer Research 2
-
- Estrogen and related hormone effects 2
-
- Advanced Breast Cancer Therapies 2
-
- Advanced biosensing and bioanalysis techniques 2
- PI3K/AKT/mTOR signaling in cancer 2
-
- Immunodeficiency and Autoimmune Disorders 2
- Co-authors
- Steffi OesterreichNancy E. DavidsonAdrian V. LeeKevin M. LevinePeilu WangZheqi LiMatthew J. SikoraDavid Chu
- Cited by
- Cancer ResearchOncologyGenetics
- Journals
- Cancer Research (1 paper)Endocrinology (1 paper)Journal of Allergy and Clinical Immunology (1 paper)
- Partner nations
- United StatesIranChina
In The Last Decade
Amir Bahreini
15 papers receiving 321 citations
Peers
Comparison fields: 5 of 44
- Cancer Research 133
- Oncology 139
- Genetics 134
- Pulmonary and Respiratory Medicine 80
- Molecular Biology 166
Countries citing papers authored by Amir Bahreini
This map shows the geographic impact of Amir Bahreini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amir Bahreini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amir Bahreini more than expected).
Fields of papers citing papers by Amir Bahreini
This network shows the impact of papers produced by Amir Bahreini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amir Bahreini. The network helps show where Amir Bahreini may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Amir Bahreini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2022 | 5 | |
| 3 | 2021 | 6 | |
| 4 | 2021 | 3 | |
| 5 | 2020 | 1 | |
| 6 | 2020 | 3 | |
| 7 | 2019 | 22 | |
| 8 | 2019 | 10 | |
| 9 | 2019 | 14 | |
| 10 | 2018 | 24 | |
| 11 | 2018 | 14 | |
| 12 | 2017 | 101 | |
| 13 | 2017 | 30 | |
| 14 | 2016 | 6 | |
| 15 | 2016 | 0 | |
| 16 | 2014 | 87 |
About Amir Bahreini
Amir Bahreini is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 16 papers that have together received 327 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (3 papers), Advanced Breast Cancer Therapies (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers), Advanced biosensing and bioanalysis techniques (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Cancer Cells and Metastasis (2 papers), Estrogen and related hormone effects (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Cancer Research (133 citations), Oncology (139 citations) and Genetics (134 citations). Amir Bahreini has collaborated with scholars based in United States, Iran and China. Frequent co-authors include Steffi Oesterreich, Nancy E. Davidson, Adrian V. Lee, Kevin M. Levine, Peilu Wang, Zheqi Li, Matthew J. Sikora, David Chu, Ben Ho Park and David J. Dabbs. Their work appears in journals such as Cancer Research, Endocrinology and Journal of Allergy and Clinical Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.